Articles by Disease (Dyskinesias)

The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly

Journal: Current Drug Safety
Volume: 1
Page: 227-241
Author(s): Subramoniam Madhusoodanan, Abhishek Sinha, Martha Sajatovic, Sanjay Gupta and Ronald Brenner

The Possible Adverse Effects of Intramuscular Botulinum Toxin Injections and their Management

Journal: Current Drug Safety
Volume: 1
Page: 271-279
Author(s): A. Magid O. Bakheit

Evaluating Drug Safety in Children and Adolescents with Bipolar Disorder

Journal: Current Drug Safety
Volume: 1
Page: 307-318
Author(s): Pamela C. Heaton, Colleen M. Garlick and Doan Tran

Pharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults

Journal: Current Psychiatry Reviews
Volume: 2
Page: 317-331
Author(s): Jonathan H. Dowson

Oestrogen-A Protective Factor in Schizophrenia?

Journal: Current Psychiatry Reviews
Volume: 2
Page: 339-352
Author(s): Heinz Hafner, Hannelore Ehrenreich, Wagner F. Gattaz, Mario R. Louza, Anita Riecher-Rossler and Jayashri Kulkarni

Treating Rapid Cycling Bipolar Disorder with Novel Medications

Journal: Current Psychiatry Reviews
Volume: 2
Page: 361-369
Author(s): Mehmet Erkan Ozcan, Geetha Shivakumar and Trisha Suppes

Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5
Page: 445-452
Author(s): Martyn D. Wood, Claire Scott, Kirsten Clarke, Katherine J. Cato, Nisha Patel, Jennie Heath, Angela Worby, Laurie Gordon, Lorraine Campbell, Graham Riley, Ceri H. Davies, Andrew Gribble and Declan N.C. Jones